Prognostic factors in Hodgkin's Lymphoma has categorized the disease into early stage and advanced stage. The aim of our study was to identify baseline prognostic factors effect on the outcome of Paediatric Hodgkin's Lymphoma patients. A total of 357 patients with newly diagnosed, biopsy proven Hodgkin's lymphoma stage I -IV were included from April 2012 to October 2015 treated with Cyclophosphamide, vincristine ,prednisone, decarbazine (COPDac) and adriamycin, b l e o m y c i n , v i n b l a s t i n e , d e c r a b a z i n e ( A B V D ) chemotherapy alone or with involved field radiotherapy. Erythrocyte sedimentation rate, Haemoglobin and albumin were independent risk factors for advanced stage Hodgkin Lymphoma.